The following links are provided by IPC for the benefit of its users and members. IPC does not attest to the accuracy of or assume any responsibility for the content or information provided by linked sites, nor does it endorse or recommend any specific content or information contained therein. Please be aware that when you exit the IPC website you are subject to the policies and procedures of the new site.
North American
In the latest Psoriasis Review IPC's bi-annual review of the latest news in the field of psoriasis. read the latest issue
Latest news Commentary: Factors associated with adverse COVID-19 outcomes in patients with psoriasis – insights from a global registry-based studyOctober 23, 2020Commentary provided on this international moderate-severe psoriasis case series, where biologics use was associated with lower risk of COVID-19-related hospitalization than non-biologic systemic therapies, however further investigation is warranted due to potential selection bias and unmeasured confounding. PsoProtect registry data on first 200 casesOctober 15, 2020PsoProtect, the global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data so that it now includes the first 200 cases. Commentary: National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic DiseaseOctober 06, 2020IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from the National Psoriasis Foundation COVID-19 Task Force. Psoriasis experts bust some myths about the diseaseOctober 05, 2020Christopher EM Griffiths and Mahira Hamdy El Sayed use science to counter misinformation about psoriasis. These two dermatologists discuss natural treatments for psoriasis, how lifestyle can affect the immune system, and the rosy future of psoriasis treatment. More News